Deliver Your News to the World

CybeRelease: (OTC PK: IDWD) and HLS Have Concluded Arrangements for $2.35 Cash Buyout for IDS Common Shares


(CybeRelease, September 19, 2006) - Lake Harmony, PA - IDS Worldwide, Inc. (OTC PK: IDWD) reported today that IDS and HLS have reached agreement on the final wording of the tender documents for the all cash buyout of IDS Worldwide, Inc. common shares for $2.35 per share. IDS executives have also agreed to the final terms for the buyout of their insider stock which will be exchanged for HLS Worldwide stock and corporate bonds. The tender document terms are now ready for the final legal review and submission to the governing agency to proceed with the tender offer. IDS believes that this cash buyout and the previous Special Dividend sufficiently meets the company’s goal of rewarding long term shareholders. HLS continued phenomenal growth rate and new cutting edge technology products being released in October will continue to reward shareholders thru their ownership of the Special Dividend Shares.

Additionally, as previously reported IDS will release details later today upon receipt of signed original documents of the Internet Portal deal signed yesterday.

To read the complete release, go to

CybeRelease Gainers are Guitar Center, Inc. (Nasdaq: GTRC), American Eagle Outfitters, Inc. (Nasdaq: AEOS), Costco Wholesale Corporation (Nasdaq: COST), ICU Medical, Inc. (Nasdaq: ICUI), Summit Bank Corporation (Nasdaq: SBGA), Sears Holdings Corporation (Nasdaq: SHLD), Performance Food Group Company (Nasdaq: PFGC) and F5 Networks, Inc. (Nasdaq: FFIV).

CybeRelease Decliners are XM Satellite Radio Holdings Inc. (Nasdaq: XMSR), Akamai Technologies, Inc. (Nasdaq: AKAM), optionsXpress Holdings, Inc. (Nasdaq: OXPS), FoxHollow Technologies, Inc. (Nasdaq: FOXH), Monster Worldwide, Inc. (Nasdaq: MNST), IDEXX Laboratories, Inc. (Nasdaq: IDXX), UCBH Holdings, Inc. (Nasdaq: UCBH) and Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $995.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.